Change of hands in Engadine. Annatina Saratz takes over the majority shareholding in Hotel Saratz. In the past financial year, the hotel achieved one of the best results in its recent history. Until now, Hotel
Kellerhals Carrard has advised Ypsomed Holding on CHF 122.5 million capital increase and listing of 1’000’000 new shares on SIX Swiss Exchange. The new registered shares were successfully listed. Ypsomed Group is a leading developer and manufacturer
Kellerhals Carrard acts as lead Swiss legal and tax counsel to Ameliora Wealth Management in the acquisition of the Swiss offshore business of UBP Investment Advisors with American private clients. With this transaction, UBP, the
Alexander Zinser will begin as Executive Search Consultant and Partner at Roy C. Hitchman in Zurich on July 2022. The company focuses on the systematic direct search for managers and specialists on an exclusive mandate basis.
MLL Legal has acted as Swiss counsel to the financial investor Capiton on the acquisition of a majority stake in the Asyril Group, a market and technology leader in flexible parts feeding systems. Capiton has
Bär & Karrer has provided legal advice to the shareholder of Home Service who has sold its shares to Investis Holding. Home Service is a Swiss-based company active in the building services sector mainly
Baker McKenzie has advised the two owners of ARGO-HYTOS Group, Christian Kienzle and FSP CAPCELLENCE, on selling their 79.5% of the shares in the company to Voith Group, a German industrial technology group. Through this deal,
Schellenberg Wittmer advised Credaris on its purchase of credit intermediary Milenia. Both companies are Switzerland’s two leading credit intermediaries, and with this purchase agreement, Credaris will acquire 100% of the shares in Milenia. The Lausanne-based
Nexenic, the foodtech start-up, has just closed its oversubscribed financing round of CHF 1.8 Million to start and accelerate the serial production and market entry of their portable mini-steamer Steasy®. The Swiss company has developed a
+ND Capital has exited Dutch cell therapy company CellPoint by sale to the Belgian biotech company Galapagos which has acquired CellPoint for $131 million upfront and up to $105 million in milestone payments. As sole venture investor
